Review
Post Screen
Cyclotides as templates in drug design

https://doi.org/10.1016/j.drudis.2009.10.007Get rights and content

Cyclotides are remarkably stable proteins from plants that have a range of pharmaceutical and agricultural applications based on both their various bioactivities and their potential for use as stable protein-engineering templates. This article discusses literature on pharmaceutically relevant activities of cyclotides, including anti-HIV, antimicrobial and cytotoxic activities, and evaluates their potential therapeutic applications. Their applications as templates for the design of antiangiogenic agents for the treatment of cancer and as anti-infective agents are also described. Toxic effects of cyclotides, whose native function is as insecticidal agents, can be removed by simple mutagenesis, thus rationalizing the apparent conundrum of proposing insecticidal agents as leads for human therapeutics.

Section snippets

Anti-HIV activity

The most extensively investigated biological activity of cyclotides is their anti-HIV activity, which was first reported by Gustafson et al. [14] as part of a screening program at the U.S. National Cancer Institute for novel anti-HIV natural products. In this study, two macrocyclic peptides (circulin A and B) from the bark of an African tree were shown to inhibit the HIV infection of different host cell lines [14]. Subsequent reports showed that a range of other cyclotides, belonging to

Toxicity

Some cyclotides have been reported to have several toxic effects, not least of which is their insecticidal activity 2, 3, 54, as well as activity against a range of other organisms, including mollusks [55], barnacles [56] and nematodes 57, 58, 59. Because none of these toxic activities are directed at mammals, they are not necessarily of concern for the development of cyclotides as human therapeutics, although the existence of any degree of toxicity needs to be taken into consideration for

Bioengineering of cyclotides

In our view, the most promising application of cyclotides as therapeutics will probably derive not from the exploitation of the bioactivities of naturally occurring examples but from the use of cyclotide structures as peptide templates for the stabilization of bioactive peptide epitopes. The potential use of cyclotides as a scaffold for therapeutic purposes has emerged, not only because of their high resistance to thermal, enzymatic and chemical degradation [5] but also because of the rapidly

Concluding remarks

Cyclotides are still at an early stage of development as therapeutics, but there are promising indications that they might prove useful in the not-too-distant future. So far, several therapeutically relevant bioactivities have been reported for a range of naturally occurring cyclotides but, in all cases, the potencies are not sufficient to justify progression into human trials, and combined with residual toxicity concerns, native cyclotides have not yet reached the clinic. A much more promising

Acknowledgements

Studies in our laboratory on cyclotides are supported by grants from the Australian Research Council (DP0880105) and the National Health and Medical Research Council (NHMRC). D.J.C. is an NHMRC Professorial Fellow. S.T.H. is a Marie Curie Postdoctoral Fellow awarded by European Commission (PIOF-GA-2008-220318).

References (68)

  • Z.O. Shenkarev

    Divalent cation coordination and mode of membrane interaction in cyclotides: NMR spatial structure of ternary complex Kalata B7/Mn2+/DPC micelle

    J. Inorg. Biochem.

    (2008)
  • Y.H. Huang

    The biological activity of the prototypic cyclotide kalata B1 is modulated by the formation of multimeric pores

    J. Biol. Chem.

    (2009)
  • A. Herrmann

    The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity

    Phytochemistry

    (2008)
  • D.W. Hoskin et al.

    Studies on anticancer activities of antimicrobial peptides

    Biochim. Biophys. Acta

    (2008)
  • H.W. Huang

    Free energies of molecular bound states in lipid bilayers: lethal concentrations of antimicrobial peptides

    Biophys. J.

    (2009)
  • L. Skjeldal

    Refined structure and metal binding site of the kalata B1 peptide

    Arch. Biochem. Biophys.

    (2002)
  • M.L. Colgrave

    Anthelmintic activity of cyclotides: in vitro studies with canine and human hookworms

    Acta Trop.

    (2009)
  • K.P. Greenwood

    The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis

    Int. J. Biochem. Cell Biol.

    (2007)
  • C.K. Wang

    Despite a conserved cystine knot motif, different cyclotides have different membrane binding modes

    Biophys. J.

    (2009)
  • C. Jennings

    Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis

    Proc. Natl. Acad. Sci. U. S. A.

    (2001)
  • B.L. Barbeta

    Plant cyclotides disrupt epithelial cells in the midgut of lepidopteran larvae

    Proc. Natl. Acad. Sci. U. S. A.

    (2008)
  • L. Gran

    Isolation of oxytocic peptides from Oldenlandia affinis by solvent extraction of tetraphenylborate complexes and chromatography on sephadex LH-20

    Lloydia

    (1973)
  • M.L. Colgrave et al.

    Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot

    Biochemistry

    (2004)
  • K. Sletten et al.

    Some molecular properties of kalata peptide B-1. A uterotonic polypeptide isolated from Oldenlandia affinis DC

    Medd. Nor. Farm. Selsk.

    (1973)
  • L. Gran

    An oxytocic principle found in Oldenlandia affinis DC

    Medd. Nor. Farm. Selsk.

    (1970)
  • O. Saether

    Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1

    Biochemistry

    (1995)
  • P.K. Pallaghy

    A common structural motif incorporating a cystine knot and a triple-stranded β-sheet in toxic and inhibitory polypeptides

    Protein Sci.

    (1994)
  • T. Schöpke

    Hämolytisch aktive komponenten aus Viola tricolor L. und Viola arvensis Murray

    Sci. Pharm.

    (1993)
  • K.M. Witherup

    Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes

    J. Nat. Prod.

    (1994)
  • K.R. Gustafson

    Circulins A and B: novel HIV-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia

    J. Am. Chem. Soc.

    (1994)
  • U. Göransson

    Seven novel macrocyclic polypeptides from Viola arvensis

    J. Nat. Prod.

    (1999)
  • P. Claeson

    Fractionation protocol for the isolation of polypeptides from plant biomass

    J. Nat. Prod.

    (1998)
  • D.J. Craik

    Discovery, structure and biological activities of the cyclotides

    Curr. Protein Pept. Sci.

    (2004)
  • A. Heitz

    Solution structure of the squash trypsin inhibitor MCoTI-II. A new family for cyclic knottins

    Biochemistry

    (2001)
  • Cited by (121)

    View all citing articles on Scopus
    View full text